Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer

Oncology Reports

Volumn 8, Issue 4, 2001, Pages 861-866

  Oshita, Fumihiro ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Elderly patient; G CSF; Lung cancer; Platinum

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG SCREENING; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; NEUTROPENIA; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMALL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; LEUKOPENIA; LUNG NEOPLASMS; MALE; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 0035405956     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.4.861     Document Type: Article

References (1)

1. Fukuoka M, Furuse K, Saijo N, et al: Randomized trials of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83: 855-861, 1991.